Propranolol Dosage Guidelines
The appropriate dosage of propranolol varies by indication, with standard maintenance doses ranging from 80-240 mg daily for most conditions, with specific titration protocols based on the condition being treated. 1
Dosing by Indication
Infantile Hemangioma
- Starting dose: 1 mg/kg/day 2
- Maintenance dose: 2 mg/kg/day for uncomplicated patients 2
- Maximum dose: 3 mg/kg/day for non-responders 2
- Administration: Divided into 2-3 daily doses 2
- Special populations:
Hypertension
- Initial dose: 80 mg once daily (extended-release) 1
- Maintenance dose: 120-160 mg once daily 1
- Maximum dose: Up to 640 mg may be required in some cases 1
- Titration: Increase gradually until adequate blood pressure control is achieved 1
Angina Pectoris
- Starting dose: 80 mg once daily (extended-release) 1
- Maintenance dose: Average optimal dose is 160 mg once daily 1
- Maximum dose: 320 mg daily (safety not established beyond this) 1
- Titration: Increase gradually at 3-7 day intervals 1
Migraine Prophylaxis
- Initial dose: 80 mg once daily (extended-release) 1
- Effective dose range: 160-240 mg once daily 3, 1
- Duration: 4-6 weeks trial to assess efficacy 1
Hypertrophic Subaortic Stenosis
- Usual dosage: 80-160 mg once daily (extended-release) 1
Administration Considerations
Extended-release formulations:
Infantile hemangioma administration:
Discontinuation:
Monitoring and Precautions
Contraindications:
Pretreatment assessment:
Common side effects:
Clinical Pearls
- Lower doses (80-160 mg daily) may provide most of the antihypertensive effect, with higher doses offering minimal additional benefit 4
- For angina, plasma levels >100 ng/ml are associated with 70-80% reduction in exercise-induced tachycardia 5
- Propranolol-hydralazine combinations may be more effective than either component alone for hypertension 6
- Low doses of propranolol (close to 1 mg/kg/day) may be effective for migraine prophylaxis in many patients 7
Remember that dosage should be carefully monitored and adjusted based on clinical response and tolerance, particularly in patients with comorbidities or at risk for adverse effects.